Literature DB >> 2220974

Successful medical management of Acanthamoeba keratitis.

S T Berger1, B J Mondino, R H Hoft, P B Donzis, G N Holland, M K Farley, J E Levenson.   

Abstract

Seven patients with documented Acanthamoeba keratitis were treated with prolonged and intensive triple antiamoebic therapy consisting of topical neomycin-polymyxin B-gramicidin, propamidine isethionate 0.1%, and miconazole nitrate 1%. Additionally, five patients were treated with topical corticosteroids. Six of seven patients were cured of Acanthamoeba keratitis with medical therapy alone, one patient required therapeutic penetrating keratoplasty to eradicate the infection. Two patients underwent penetrating keratoplasty to improve their vision after medical therapy. Our series differs from previous reports in that triple antiamoebic therapy was used in all seven patients and was successful in both early and advanced cases of Acanthamoeba keratitis. Prolonged and intensive topical therapy with these three antiamoebic drugs may be an effective mode of therapy for Acanthamoeba keratitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2220974     DOI: 10.1016/s0002-9394(14)77020-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

Review 1.  Persistent acanthamoeba keratitis in a non-contact lens wearer following exposure to bird seed dust.

Authors:  P P Syam; R Narendran; J van der Hoek
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 2.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 3.  Common ocular infections. A prescriber's guide.

Authors:  S P Donahue; J M Khoury; R P Kowalski
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

4.  Susceptibility of Acanthamoeba castellanii to contact lens disinfecting solutions.

Authors:  S Zanetti; P L Fiori; A Pinna; S Usai; F Carta; G Fadda
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

5.  Infectious scleritis: report of four cases.

Authors:  M Sainz de la Maza; R K Hemady; C S Foster
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 6.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

7.  Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga.

Authors:  D Perrine; J P Chenu; P Georges; J C Lancelot; C Saturnino; M Robba
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Clinical and histologic evaluations of experimental Acanthamoeba keratitis.

Authors:  Zubeyde Akin Polat; Semra Ozcelik; Ayse Vural; Esin Yildiz; Ali Cetin
Journal:  Parasitol Res       Date:  2007-08-14       Impact factor: 2.289

9.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

10.  Diversity of microbial species implicated in keratitis: a review.

Authors:  Elisabeth Karsten; Stephanie Lousie Watson; Leslie John Ray Foster
Journal:  Open Ophthalmol J       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.